辰欣药业：关于持股5%以上股东减持股份计划完成暨减持股份结果公告

Group 1 - The core point of the article is that Shijiazhuang Four Drug Co., Ltd. has completed a share reduction plan for its holdings in Chenxin Pharmaceutical, reducing its stake from 6.11% to 5.11% [2][2] - Before the reduction, Shijiazhuang Four Drug held 27,661,441 shares of Chenxin Pharmaceutical, which accounted for 6.11% of the total share capital [2][2] - As of September 24, 2025, Shijiazhuang Four Drug has reduced its holdings by 4,520,000 shares, representing 0.998% of the total share capital of Chenxin Pharmaceutical [2][2]